Biblio
Export 1129 results:
Author [ Title
Filters: First Letter Of Last Name is T [Clear All Filters]
“Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 707-21, 2016.
, “A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.”, J Alzheimers Dis, vol. 57, no. 2, pp. 613-623, 2017.
, “Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.”, J Alzheimers Dis, vol. 56, no. 2, pp. 585-599, 2017.
, “A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological Features.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1167-1174, 2017.
, “A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 2, pp. 731-45, 2016.
, “Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1097-1111, 2017.
, “A Novel and Intelligent Home Monitoring System for Care Support of Elders with Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1561-1591, 2016.
, “A Novel and Intelligent Home Monitoring System for Care Support of Elders with Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1561-1591, 2016.
, “Normal Amplitude of Electroretinography and Visual Evoked Potential Responses in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 51, no. 1, pp. 21-6, 2016.
, “Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1437-1451, 2018.
, “Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.”, J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.
, “Non-Genetic Risk Factors for Degenerative and Vascular Young Onset Dementia: Results from the INSPIRED and KGOW Studies.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1747-1758, 2018.
, “Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
, “NO-Dependent Akt Inactivation by S-Nitrosylation as a Possible Mechanism of STZ-Induced Neuronal Insulin Resistance.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1427-1443, 2018.
, “No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 85-99, 2017.
, “Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1683-1692, 2017.
, “A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”, J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
, “A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”, J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
, “A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”, J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
, “A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”, J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
, “A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 64, no. 1, pp. 1-16, 2018.
, “A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 64, no. 1, pp. 1-16, 2018.
, “Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.”, J Alzheimers Dis, vol. 82, no. 2, pp. 631-646, 2021.
, “Neuropsychological Markers of Medial Perirhinal and Entorhinal Cortex Functioning are Impaired Twelve Years Preceding Diagnosis of Alzheimer's Dementia.”, J Alzheimers Dis, vol. 52, no. 2, pp. 573-80, 2016.
, “Neuropsychological Features of Microbleeds and Cortical Microinfarct Detected by High Resolution Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 53, no. 1, pp. 315-25, 2016.
,